nodes	percent_of_prediction	percent_of_DWPC	metapath
Nortriptyline—SLC6A4—attention deficit hyperactivity disorder	0.263	0.362	CbGaD
Nortriptyline—DRD2—attention deficit hyperactivity disorder	0.262	0.36	CbGaD
Nortriptyline—HTR2A—attention deficit hyperactivity disorder	0.202	0.278	CbGaD
Nortriptyline—SLC6A2—locus ceruleus—attention deficit hyperactivity disorder	0.00718	0.0916	CbGeAlD
Nortriptyline—ORM1—saliva—attention deficit hyperactivity disorder	0.00497	0.0634	CbGeAlD
Nortriptyline—HTR2A—locus ceruleus—attention deficit hyperactivity disorder	0.00431	0.055	CbGeAlD
Nortriptyline—SLC6A2—autonomic nervous system—attention deficit hyperactivity disorder	0.00381	0.0487	CbGeAlD
Nortriptyline—HTR2A—autonomic nervous system—attention deficit hyperactivity disorder	0.00229	0.0292	CbGeAlD
Nortriptyline—HTR6—forebrain—attention deficit hyperactivity disorder	0.00184	0.0235	CbGeAlD
Nortriptyline—ADRA1D—forebrain—attention deficit hyperactivity disorder	0.00144	0.0184	CbGeAlD
Nortriptyline—CHRM4—nervous system—attention deficit hyperactivity disorder	0.00112	0.0143	CbGeAlD
Nortriptyline—CHRM2—forebrain—attention deficit hyperactivity disorder	0.0011	0.0141	CbGeAlD
Nortriptyline—CHRM4—central nervous system—attention deficit hyperactivity disorder	0.00108	0.0137	CbGeAlD
Nortriptyline—HTR2C—forebrain—attention deficit hyperactivity disorder	0.00106	0.0136	CbGeAlD
Nortriptyline—SLC6A4—forebrain—attention deficit hyperactivity disorder	0.00101	0.0129	CbGeAlD
Nortriptyline—CHRM1—forebrain—attention deficit hyperactivity disorder	0.00101	0.0128	CbGeAlD
Nortriptyline—HTR6—nervous system—attention deficit hyperactivity disorder	0.001	0.0128	CbGeAlD
Nortriptyline—HTR6—central nervous system—attention deficit hyperactivity disorder	0.000963	0.0123	CbGeAlD
Nortriptyline—CHRM2—cardiovascular system—attention deficit hyperactivity disorder	0.000934	0.0119	CbGeAlD
Nortriptyline—CHRM3—forebrain—attention deficit hyperactivity disorder	0.0009	0.0115	CbGeAlD
Nortriptyline—HTR1A—forebrain—attention deficit hyperactivity disorder	0.000896	0.0114	CbGeAlD
Nortriptyline—SLC6A2—forebrain—attention deficit hyperactivity disorder	0.000889	0.0113	CbGeAlD
Nortriptyline—CHRM5—nervous system—attention deficit hyperactivity disorder	0.000874	0.0111	CbGeAlD
Nortriptyline—CHRM4—brain—attention deficit hyperactivity disorder	0.000854	0.0109	CbGeAlD
Nortriptyline—CHRM1—cardiovascular system—attention deficit hyperactivity disorder	0.00085	0.0109	CbGeAlD
Nortriptyline—CHRM5—central nervous system—attention deficit hyperactivity disorder	0.000841	0.0107	CbGeAlD
Nortriptyline—ADRA1A—forebrain—attention deficit hyperactivity disorder	0.000826	0.0105	CbGeAlD
Nortriptyline—DRD2—forebrain—attention deficit hyperactivity disorder	0.00081	0.0103	CbGeAlD
Nortriptyline—ADRA1B—nervous system—attention deficit hyperactivity disorder	0.000798	0.0102	CbGeAlD
Nortriptyline—ADRA1D—nervous system—attention deficit hyperactivity disorder	0.000781	0.00996	CbGeAlD
Nortriptyline—ADRA1B—central nervous system—attention deficit hyperactivity disorder	0.000768	0.00981	CbGeAlD
Nortriptyline—HTR6—brain—attention deficit hyperactivity disorder	0.000764	0.00976	CbGeAlD
Nortriptyline—HTR1A—cardiovascular system—attention deficit hyperactivity disorder	0.000758	0.00967	CbGeAlD
Nortriptyline—ADRA1D—central nervous system—attention deficit hyperactivity disorder	0.000752	0.00959	CbGeAlD
Nortriptyline—HTR2C—midbrain—attention deficit hyperactivity disorder	0.000703	0.00897	CbGeAlD
Nortriptyline—ADRA1A—cardiovascular system—attention deficit hyperactivity disorder	0.000699	0.00891	CbGeAlD
Nortriptyline—CHRM5—brain—attention deficit hyperactivity disorder	0.000668	0.00852	CbGeAlD
Nortriptyline—SLC6A4—midbrain—attention deficit hyperactivity disorder	0.000666	0.00851	CbGeAlD
Nortriptyline—ORM1—nervous system—attention deficit hyperactivity disorder	0.000643	0.00821	CbGeAlD
Nortriptyline—HRH1—forebrain—attention deficit hyperactivity disorder	0.000639	0.00816	CbGeAlD
Nortriptyline—ORM1—central nervous system—attention deficit hyperactivity disorder	0.000619	0.0079	CbGeAlD
Nortriptyline—ADRA1B—brain—attention deficit hyperactivity disorder	0.00061	0.00779	CbGeAlD
Nortriptyline—CHRM2—nervous system—attention deficit hyperactivity disorder	0.0006	0.00765	CbGeAlD
Nortriptyline—ADRA1D—brain—attention deficit hyperactivity disorder	0.000597	0.00762	CbGeAlD
Nortriptyline—PTGS1—forebrain—attention deficit hyperactivity disorder	0.000592	0.00755	CbGeAlD
Nortriptyline—HTR1A—midbrain—attention deficit hyperactivity disorder	0.000592	0.00755	CbGeAlD
Nortriptyline—HTR2C—nervous system—attention deficit hyperactivity disorder	0.000578	0.00738	CbGeAlD
Nortriptyline—CHRM2—central nervous system—attention deficit hyperactivity disorder	0.000577	0.00737	CbGeAlD
Nortriptyline—HTR2C—central nervous system—attention deficit hyperactivity disorder	0.000556	0.0071	CbGeAlD
Nortriptyline—CYP2C9—cardiovascular system—attention deficit hyperactivity disorder	0.000548	0.007	CbGeAlD
Nortriptyline—SLC6A4—nervous system—attention deficit hyperactivity disorder	0.000548	0.00699	CbGeAlD
Nortriptyline—CHRM1—nervous system—attention deficit hyperactivity disorder	0.000546	0.00697	CbGeAlD
Nortriptyline—DRD2—midbrain—attention deficit hyperactivity disorder	0.000535	0.00682	CbGeAlD
Nortriptyline—HTR2A—forebrain—attention deficit hyperactivity disorder	0.000534	0.00682	CbGeAlD
Nortriptyline—SLC6A4—central nervous system—attention deficit hyperactivity disorder	0.000528	0.00673	CbGeAlD
Nortriptyline—CHRM1—central nervous system—attention deficit hyperactivity disorder	0.000525	0.00671	CbGeAlD
Nortriptyline—CYP2E1—cardiovascular system—attention deficit hyperactivity disorder	0.00052	0.00663	CbGeAlD
Nortriptyline—PTGS1—cardiovascular system—attention deficit hyperactivity disorder	0.000501	0.00639	CbGeAlD
Nortriptyline—CHRM3—nervous system—attention deficit hyperactivity disorder	0.000488	0.00623	CbGeAlD
Nortriptyline—CYP2D6—forebrain—attention deficit hyperactivity disorder	0.000487	0.00621	CbGeAlD
Nortriptyline—HTR1A—nervous system—attention deficit hyperactivity disorder	0.000486	0.00621	CbGeAlD
Nortriptyline—SLC6A2—nervous system—attention deficit hyperactivity disorder	0.000482	0.00616	CbGeAlD
Nortriptyline—CHRM3—central nervous system—attention deficit hyperactivity disorder	0.00047	0.006	CbGeAlD
Nortriptyline—HTR1A—central nervous system—attention deficit hyperactivity disorder	0.000468	0.00598	CbGeAlD
Nortriptyline—Mianserin—ADRA2C—attention deficit hyperactivity disorder	0.000465	0.0548	CrCbGaD
Nortriptyline—SLC6A2—central nervous system—attention deficit hyperactivity disorder	0.000464	0.00593	CbGeAlD
Nortriptyline—CHRM2—brain—attention deficit hyperactivity disorder	0.000458	0.00585	CbGeAlD
Nortriptyline—HTR1A—cerebellum—attention deficit hyperactivity disorder	0.000458	0.00584	CbGeAlD
Nortriptyline—HTR2A—cardiovascular system—attention deficit hyperactivity disorder	0.000452	0.00576	CbGeAlD
Nortriptyline—ADRA1A—nervous system—attention deficit hyperactivity disorder	0.000448	0.00572	CbGeAlD
Nortriptyline—HTR2C—brain—attention deficit hyperactivity disorder	0.000442	0.00564	CbGeAlD
Nortriptyline—DRD2—nervous system—attention deficit hyperactivity disorder	0.00044	0.00561	CbGeAlD
Nortriptyline—ADRA1A—central nervous system—attention deficit hyperactivity disorder	0.000432	0.00551	CbGeAlD
Nortriptyline—ALB—brain—attention deficit hyperactivity disorder	0.000431	0.0055	CbGeAlD
Nortriptyline—DRD2—central nervous system—attention deficit hyperactivity disorder	0.000423	0.0054	CbGeAlD
Nortriptyline—ADRA1A—cerebellum—attention deficit hyperactivity disorder	0.000422	0.00539	CbGeAlD
Nortriptyline—SLC6A4—brain—attention deficit hyperactivity disorder	0.000419	0.00534	CbGeAlD
Nortriptyline—CHRM1—brain—attention deficit hyperactivity disorder	0.000417	0.00532	CbGeAlD
Nortriptyline—DRD2—cerebellum—attention deficit hyperactivity disorder	0.000414	0.00528	CbGeAlD
Nortriptyline—CHRM3—brain—attention deficit hyperactivity disorder	0.000373	0.00476	CbGeAlD
Nortriptyline—Doxepin—ADRA2C—attention deficit hyperactivity disorder	0.000373	0.044	CrCbGaD
Nortriptyline—HTR1A—brain—attention deficit hyperactivity disorder	0.000372	0.00475	CbGeAlD
Nortriptyline—SLC6A2—brain—attention deficit hyperactivity disorder	0.000369	0.00471	CbGeAlD
Nortriptyline—Protriptyline—SLC6A4—attention deficit hyperactivity disorder	0.000353	0.0416	CrCbGaD
Nortriptyline—HTR2A—midbrain—attention deficit hyperactivity disorder	0.000353	0.0045	CbGeAlD
Nortriptyline—HRH1—nervous system—attention deficit hyperactivity disorder	0.000347	0.00443	CbGeAlD
Nortriptyline—Epinastine—ADRA2A—attention deficit hyperactivity disorder	0.000343	0.0404	CrCbGaD
Nortriptyline—ADRA1A—brain—attention deficit hyperactivity disorder	0.000343	0.00437	CbGeAlD
Nortriptyline—DRD2—brain—attention deficit hyperactivity disorder	0.000336	0.00429	CbGeAlD
Nortriptyline—HRH1—central nervous system—attention deficit hyperactivity disorder	0.000334	0.00427	CbGeAlD
Nortriptyline—CYP2E1—nervous system—attention deficit hyperactivity disorder	0.000334	0.00426	CbGeAlD
Nortriptyline—PTGS1—nervous system—attention deficit hyperactivity disorder	0.000321	0.0041	CbGeAlD
Nortriptyline—CYP2E1—central nervous system—attention deficit hyperactivity disorder	0.000321	0.0041	CbGeAlD
Nortriptyline—CYP2E1—cerebellum—attention deficit hyperactivity disorder	0.000314	0.00401	CbGeAlD
Nortriptyline—PTGS1—central nervous system—attention deficit hyperactivity disorder	0.000309	0.00395	CbGeAlD
Nortriptyline—Maprotiline—SLC6A3—attention deficit hyperactivity disorder	0.000301	0.0355	CrCbGaD
Nortriptyline—HTR2A—nervous system—attention deficit hyperactivity disorder	0.00029	0.0037	CbGeAlD
Nortriptyline—HTR2A—central nervous system—attention deficit hyperactivity disorder	0.000279	0.00356	CbGeAlD
Nortriptyline—HTR2A—cerebellum—attention deficit hyperactivity disorder	0.000273	0.00348	CbGeAlD
Nortriptyline—CYP3A4—nervous system—attention deficit hyperactivity disorder	0.000268	0.00343	CbGeAlD
Nortriptyline—HRH1—brain—attention deficit hyperactivity disorder	0.000265	0.00339	CbGeAlD
Nortriptyline—CYP2D6—nervous system—attention deficit hyperactivity disorder	0.000264	0.00337	CbGeAlD
Nortriptyline—CYP3A4—central nervous system—attention deficit hyperactivity disorder	0.000258	0.0033	CbGeAlD
Nortriptyline—CYP2E1—brain—attention deficit hyperactivity disorder	0.000255	0.00325	CbGeAlD
Nortriptyline—CYP2D6—central nervous system—attention deficit hyperactivity disorder	0.000254	0.00325	CbGeAlD
Nortriptyline—CYP2D6—cerebellum—attention deficit hyperactivity disorder	0.000249	0.00317	CbGeAlD
Nortriptyline—PTGS1—brain—attention deficit hyperactivity disorder	0.000246	0.00313	CbGeAlD
Nortriptyline—Atomoxetine—HTR1B—attention deficit hyperactivity disorder	0.000229	0.027	CrCbGaD
Nortriptyline—Maprotiline—DRD2—attention deficit hyperactivity disorder	0.000224	0.0264	CrCbGaD
Nortriptyline—HTR2A—brain—attention deficit hyperactivity disorder	0.000222	0.00283	CbGeAlD
Nortriptyline—Mianserin—DRD3—attention deficit hyperactivity disorder	0.000218	0.0256	CrCbGaD
Nortriptyline—Atomoxetine—SLC6A3—attention deficit hyperactivity disorder	0.000207	0.0244	CrCbGaD
Nortriptyline—Cyclobenzaprine—HTR2A—attention deficit hyperactivity disorder	0.000203	0.0239	CrCbGaD
Nortriptyline—Mianserin—SLC6A3—attention deficit hyperactivity disorder	0.000202	0.0239	CrCbGaD
Nortriptyline—CYP2D6—brain—attention deficit hyperactivity disorder	0.000202	0.00258	CbGeAlD
Nortriptyline—Epinastine—HTR2A—attention deficit hyperactivity disorder	0.000201	0.0237	CrCbGaD
Nortriptyline—Cyproheptadine—DRD2—attention deficit hyperactivity disorder	0.000199	0.0234	CrCbGaD
Nortriptyline—Mianserin—ADRA2A—attention deficit hyperactivity disorder	0.000198	0.0234	CrCbGaD
Nortriptyline—Chlorprothixene—DRD3—attention deficit hyperactivity disorder	0.000198	0.0234	CrCbGaD
Nortriptyline—Chlorprothixene—DRD1—attention deficit hyperactivity disorder	0.000194	0.0229	CrCbGaD
Nortriptyline—Clomipramine—ADRA2A—attention deficit hyperactivity disorder	0.000182	0.0214	CrCbGaD
Nortriptyline—Maprotiline—HTR2A—attention deficit hyperactivity disorder	0.000173	0.0204	CrCbGaD
Nortriptyline—Trimipramine—SLC6A3—attention deficit hyperactivity disorder	0.00017	0.0201	CrCbGaD
Nortriptyline—Trimipramine—ADRA2A—attention deficit hyperactivity disorder	0.000167	0.0197	CrCbGaD
Nortriptyline—Doxepin—ADRA2A—attention deficit hyperactivity disorder	0.000159	0.0188	CrCbGaD
Nortriptyline—Atomoxetine—SLC6A4—attention deficit hyperactivity disorder	0.000155	0.0183	CrCbGaD
Nortriptyline—Cyproheptadine—HTR2A—attention deficit hyperactivity disorder	0.000154	0.0181	CrCbGaD
Nortriptyline—Mianserin—SLC6A4—attention deficit hyperactivity disorder	0.000151	0.0178	CrCbGaD
Nortriptyline—Mianserin—DRD2—attention deficit hyperactivity disorder	0.000151	0.0177	CrCbGaD
Nortriptyline—Desipramine—SLC6A3—attention deficit hyperactivity disorder	0.000149	0.0176	CrCbGaD
Nortriptyline—Amitriptyline—HTR1B—attention deficit hyperactivity disorder	0.000139	0.0164	CrCbGaD
Nortriptyline—Clomipramine—SLC6A4—attention deficit hyperactivity disorder	0.000138	0.0163	CrCbGaD
Nortriptyline—Chlorprothixene—DRD2—attention deficit hyperactivity disorder	0.000137	0.0162	CrCbGaD
Nortriptyline—Amitriptyline—DRD3—attention deficit hyperactivity disorder	0.000135	0.0159	CrCbGaD
Nortriptyline—Trimipramine—SLC6A4—attention deficit hyperactivity disorder	0.000127	0.015	CrCbGaD
Nortriptyline—Trimipramine—DRD2—attention deficit hyperactivity disorder	0.000127	0.0149	CrCbGaD
Nortriptyline—Imipramine—SLC6A3—attention deficit hyperactivity disorder	0.000126	0.0149	CrCbGaD
Nortriptyline—Amitriptyline—ADRA2A—attention deficit hyperactivity disorder	0.000123	0.0145	CrCbGaD
Nortriptyline—Doxepin—SLC6A4—attention deficit hyperactivity disorder	0.000121	0.0143	CrCbGaD
Nortriptyline—Doxepin—DRD2—attention deficit hyperactivity disorder	0.000121	0.0142	CrCbGaD
Nortriptyline—Atomoxetine—HTR2A—attention deficit hyperactivity disorder	0.000119	0.014	CrCbGaD
Nortriptyline—Mianserin—HTR2A—attention deficit hyperactivity disorder	0.000116	0.0137	CrCbGaD
Nortriptyline—Desipramine—SLC6A4—attention deficit hyperactivity disorder	0.000111	0.0131	CrCbGaD
Nortriptyline—Desipramine—DRD2—attention deficit hyperactivity disorder	0.000111	0.0131	CrCbGaD
Nortriptyline—Clomipramine—HTR2A—attention deficit hyperactivity disorder	0.000106	0.0125	CrCbGaD
Nortriptyline—Chlorprothixene—HTR2A—attention deficit hyperactivity disorder	0.000106	0.0125	CrCbGaD
Nortriptyline—Trimipramine—HTR2A—attention deficit hyperactivity disorder	9.79e-05	0.0115	CrCbGaD
Nortriptyline—Imipramine—SLC6A4—attention deficit hyperactivity disorder	9.45e-05	0.0111	CrCbGaD
Nortriptyline—Imipramine—DRD2—attention deficit hyperactivity disorder	9.4e-05	0.0111	CrCbGaD
Nortriptyline—Amitriptyline—SLC6A4—attention deficit hyperactivity disorder	9.39e-05	0.0111	CrCbGaD
Nortriptyline—Amitriptyline—DRD2—attention deficit hyperactivity disorder	9.34e-05	0.011	CrCbGaD
Nortriptyline—Doxepin—HTR2A—attention deficit hyperactivity disorder	9.33e-05	0.011	CrCbGaD
Nortriptyline—Desipramine—HTR2A—attention deficit hyperactivity disorder	8.56e-05	0.0101	CrCbGaD
Nortriptyline—Imipramine—HTR2A—attention deficit hyperactivity disorder	7.26e-05	0.00856	CrCbGaD
Nortriptyline—Amitriptyline—HTR2A—attention deficit hyperactivity disorder	7.22e-05	0.00851	CrCbGaD
Nortriptyline—CHRM2—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	1.85e-05	9.92e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	1.84e-05	9.89e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	1.84e-05	9.89e-05	CbGpPWpGaD
Nortriptyline—HTR6—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	1.83e-05	9.8e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	1.82e-05	9.79e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	1.82e-05	9.77e-05	CbGpPWpGaD
Nortriptyline—ALB—Metabolism—ADRA2C—attention deficit hyperactivity disorder	1.82e-05	9.75e-05	CbGpPWpGaD
Nortriptyline—CHRM4—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	1.79e-05	9.6e-05	CbGpPWpGaD
Nortriptyline—PTGS1—Metabolism—CACNA1C—attention deficit hyperactivity disorder	1.79e-05	9.59e-05	CbGpPWpGaD
Nortriptyline—CHRM5—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	1.77e-05	9.52e-05	CbGpPWpGaD
Nortriptyline—ADRA1D—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	1.77e-05	9.52e-05	CbGpPWpGaD
Nortriptyline—HTR6—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	1.77e-05	9.49e-05	CbGpPWpGaD
Nortriptyline—HTR6—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	1.74e-05	9.33e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Metabolism—TPH2—attention deficit hyperactivity disorder	1.73e-05	9.3e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Metabolism—CACNB2—attention deficit hyperactivity disorder	1.73e-05	9.3e-05	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	1.73e-05	9.29e-05	CbGpPWpGaD
Nortriptyline—HRH1—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	1.73e-05	9.27e-05	CbGpPWpGaD
Nortriptyline—CHRM4—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	1.72e-05	9.25e-05	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	1.72e-05	9.24e-05	CbGpPWpGaD
Nortriptyline—HTR6—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	1.72e-05	9.21e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	1.72e-05	9.21e-05	CbGpPWpGaD
Nortriptyline—CHRM5—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	1.71e-05	9.19e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Metabolism—DPYD—attention deficit hyperactivity disorder	1.7e-05	9.15e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	1.7e-05	9.12e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	1.69e-05	9.1e-05	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	1.67e-05	8.95e-05	CbGpPWpGaD
Nortriptyline—CHRM4—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	1.67e-05	8.95e-05	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	1.66e-05	8.93e-05	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	1.65e-05	8.88e-05	CbGpPWpGaD
Nortriptyline—CHRM5—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	1.65e-05	8.85e-05	CbGpPWpGaD
Nortriptyline—CHRM4—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	1.64e-05	8.8e-05	CbGpPWpGaD
Nortriptyline—CYP2C19—Metabolism—ADRA2C—attention deficit hyperactivity disorder	1.63e-05	8.75e-05	CbGpPWpGaD
Nortriptyline—CHRM4—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	1.62e-05	8.69e-05	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	1.61e-05	8.64e-05	CbGpPWpGaD
Nortriptyline—HTR6—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	1.6e-05	8.58e-05	CbGpPWpGaD
Nortriptyline—CHRM5—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	1.6e-05	8.57e-05	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	1.58e-05	8.5e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Metabolism—CACNA1C—attention deficit hyperactivity disorder	1.58e-05	8.5e-05	CbGpPWpGaD
Nortriptyline—CHRM5—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	1.57e-05	8.43e-05	CbGpPWpGaD
Nortriptyline—PTGS1—Metabolism—SNAP25—attention deficit hyperactivity disorder	1.56e-05	8.38e-05	CbGpPWpGaD
Nortriptyline—CHRM5—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	1.55e-05	8.32e-05	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	1.55e-05	8.32e-05	CbGpPWpGaD
Nortriptyline—HTR1A—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	1.55e-05	8.3e-05	CbGpPWpGaD
Nortriptyline—HTR2C—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	1.54e-05	8.25e-05	CbGpPWpGaD
Nortriptyline—CHRM4—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	1.51e-05	8.1e-05	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	1.5e-05	8.06e-05	CbGpPWpGaD
Nortriptyline—CYP2D6—Metabolism—ADRA2C—attention deficit hyperactivity disorder	1.5e-05	8.05e-05	CbGpPWpGaD
Nortriptyline—CYP2C9—Metabolism—ADRA2C—attention deficit hyperactivity disorder	1.49e-05	7.98e-05	CbGpPWpGaD
Nortriptyline—PTGS1—Metabolism—ADRA2A—attention deficit hyperactivity disorder	1.49e-05	7.98e-05	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	1.48e-05	7.92e-05	CbGpPWpGaD
Nortriptyline—ADRA1B—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	1.47e-05	7.9e-05	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	1.46e-05	7.84e-05	CbGpPWpGaD
Nortriptyline—CYP2E1—Metabolism—TPH2—attention deficit hyperactivity disorder	1.46e-05	7.83e-05	CbGpPWpGaD
Nortriptyline—CYP2E1—Metabolism—CACNB2—attention deficit hyperactivity disorder	1.46e-05	7.83e-05	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	1.46e-05	7.83e-05	CbGpPWpGaD
Nortriptyline—CYP3A5—Metabolism—TPH2—attention deficit hyperactivity disorder	1.46e-05	7.82e-05	CbGpPWpGaD
Nortriptyline—CYP3A5—Metabolism—CACNB2—attention deficit hyperactivity disorder	1.46e-05	7.82e-05	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	1.45e-05	7.8e-05	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	1.45e-05	7.76e-05	CbGpPWpGaD
Nortriptyline—CHRM5—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	1.44e-05	7.75e-05	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	1.44e-05	7.71e-05	CbGpPWpGaD
Nortriptyline—CYP2E1—Metabolism—DPYD—attention deficit hyperactivity disorder	1.44e-05	7.71e-05	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	1.43e-05	7.7e-05	CbGpPWpGaD
Nortriptyline—CYP3A5—Metabolism—DPYD—attention deficit hyperactivity disorder	1.43e-05	7.69e-05	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	1.43e-05	7.67e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	1.42e-05	7.65e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	1.41e-05	7.57e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	1.41e-05	7.55e-05	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	1.4e-05	7.53e-05	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	1.4e-05	7.49e-05	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	1.38e-05	7.43e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Metabolism—SNAP25—attention deficit hyperactivity disorder	1.38e-05	7.43e-05	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	1.36e-05	7.29e-05	CbGpPWpGaD
Nortriptyline—DRD2—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	1.36e-05	7.28e-05	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	1.35e-05	7.25e-05	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	1.34e-05	7.22e-05	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	1.34e-05	7.17e-05	CbGpPWpGaD
Nortriptyline—CYP2E1—Metabolism—CACNA1C—attention deficit hyperactivity disorder	1.33e-05	7.16e-05	CbGpPWpGaD
Nortriptyline—HRH1—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	1.33e-05	7.15e-05	CbGpPWpGaD
Nortriptyline—CYP3A5—Metabolism—CACNA1C—attention deficit hyperactivity disorder	1.33e-05	7.15e-05	CbGpPWpGaD
Nortriptyline—CHRM1—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	1.33e-05	7.13e-05	CbGpPWpGaD
Nortriptyline—CHRM3—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	1.32e-05	7.11e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Metabolism—ADRA2A—attention deficit hyperactivity disorder	1.32e-05	7.07e-05	CbGpPWpGaD
Nortriptyline—CHRM2—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	1.31e-05	7.04e-05	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	1.31e-05	7.03e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	1.31e-05	7.02e-05	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	1.3e-05	6.99e-05	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	1.29e-05	6.91e-05	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	1.29e-05	6.91e-05	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	1.28e-05	6.87e-05	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	1.28e-05	6.85e-05	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism—ADRA2C—attention deficit hyperactivity disorder	1.27e-05	6.82e-05	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	1.27e-05	6.82e-05	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	1.26e-05	6.79e-05	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	1.26e-05	6.74e-05	CbGpPWpGaD
Nortriptyline—ALB—Metabolism—TPH2—attention deficit hyperactivity disorder	1.25e-05	6.73e-05	CbGpPWpGaD
Nortriptyline—ALB—Metabolism—CACNB2—attention deficit hyperactivity disorder	1.25e-05	6.73e-05	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	1.25e-05	6.73e-05	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	1.25e-05	6.71e-05	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	1.25e-05	6.69e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	1.25e-05	6.68e-05	CbGpPWpGaD
Nortriptyline—ALB—Metabolism—DPYD—attention deficit hyperactivity disorder	1.23e-05	6.62e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	1.23e-05	6.62e-05	CbGpPWpGaD
Nortriptyline—DRD2—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	1.23e-05	6.61e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	1.23e-05	6.6e-05	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	1.23e-05	6.58e-05	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	1.21e-05	6.5e-05	CbGpPWpGaD
Nortriptyline—HRH1—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	1.21e-05	6.49e-05	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	1.21e-05	6.47e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	1.2e-05	6.45e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	1.19e-05	6.39e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	1.19e-05	6.37e-05	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	1.19e-05	6.37e-05	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	1.18e-05	6.35e-05	CbGpPWpGaD
Nortriptyline—PTGS1—Metabolism—COMT—attention deficit hyperactivity disorder	1.18e-05	6.35e-05	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	1.18e-05	6.32e-05	CbGpPWpGaD
Nortriptyline—PTGS1—Metabolism—MAOA—attention deficit hyperactivity disorder	1.17e-05	6.31e-05	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	1.17e-05	6.27e-05	CbGpPWpGaD
Nortriptyline—CYP2E1—Metabolism—SNAP25—attention deficit hyperactivity disorder	1.17e-05	6.26e-05	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	1.16e-05	6.25e-05	CbGpPWpGaD
Nortriptyline—CYP3A5—Metabolism—SNAP25—attention deficit hyperactivity disorder	1.16e-05	6.25e-05	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	1.16e-05	6.23e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	1.16e-05	6.21e-05	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	1.15e-05	6.17e-05	CbGpPWpGaD
Nortriptyline—ALB—Metabolism—CACNA1C—attention deficit hyperactivity disorder	1.15e-05	6.16e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	1.15e-05	6.15e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	1.14e-05	6.14e-05	CbGpPWpGaD
Nortriptyline—PTGS1—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	1.14e-05	6.11e-05	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	1.13e-05	6.07e-05	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	1.13e-05	6.06e-05	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	1.13e-05	6.06e-05	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	1.13e-05	6.05e-05	CbGpPWpGaD
Nortriptyline—CYP2C19—Metabolism—TPH2—attention deficit hyperactivity disorder	1.13e-05	6.04e-05	CbGpPWpGaD
Nortriptyline—CYP2C19—Metabolism—CACNB2—attention deficit hyperactivity disorder	1.13e-05	6.04e-05	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	1.12e-05	6.04e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	1.12e-05	6.02e-05	CbGpPWpGaD
Nortriptyline—HTR6—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	1.12e-05	6.01e-05	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	1.12e-05	5.99e-05	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	1.11e-05	5.97e-05	CbGpPWpGaD
Nortriptyline—CYP2E1—Metabolism—ADRA2A—attention deficit hyperactivity disorder	1.11e-05	5.96e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	1.11e-05	5.96e-05	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	1.11e-05	5.95e-05	CbGpPWpGaD
Nortriptyline—CYP3A5—Metabolism—ADRA2A—attention deficit hyperactivity disorder	1.11e-05	5.95e-05	CbGpPWpGaD
Nortriptyline—CYP2C19—Metabolism—DPYD—attention deficit hyperactivity disorder	1.11e-05	5.95e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	1.11e-05	5.94e-05	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	1.11e-05	5.93e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	1.1e-05	5.92e-05	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	1.1e-05	5.89e-05	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	1.1e-05	5.88e-05	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	1.09e-05	5.86e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	1.09e-05	5.86e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	1.09e-05	5.84e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	1.09e-05	5.84e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	1.08e-05	5.79e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	1.07e-05	5.77e-05	CbGpPWpGaD
Nortriptyline—CHRM4—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	1.06e-05	5.67e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Metabolism—COMT—attention deficit hyperactivity disorder	1.05e-05	5.63e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Metabolism—MAOA—attention deficit hyperactivity disorder	1.04e-05	5.59e-05	CbGpPWpGaD
Nortriptyline—CYP2D6—Metabolism—TPH2—attention deficit hyperactivity disorder	1.04e-05	5.56e-05	CbGpPWpGaD
Nortriptyline—CYP2D6—Metabolism—CACNB2—attention deficit hyperactivity disorder	1.04e-05	5.56e-05	CbGpPWpGaD
Nortriptyline—CYP2C19—Metabolism—CACNA1C—attention deficit hyperactivity disorder	1.03e-05	5.53e-05	CbGpPWpGaD
Nortriptyline—CYP2C9—Metabolism—TPH2—attention deficit hyperactivity disorder	1.03e-05	5.51e-05	CbGpPWpGaD
Nortriptyline—CYP2C9—Metabolism—CACNB2—attention deficit hyperactivity disorder	1.03e-05	5.51e-05	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	1.02e-05	5.49e-05	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	1.02e-05	5.48e-05	CbGpPWpGaD
Nortriptyline—CYP2D6—Metabolism—DPYD—attention deficit hyperactivity disorder	1.02e-05	5.47e-05	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	1.02e-05	5.46e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	1.01e-05	5.44e-05	CbGpPWpGaD
Nortriptyline—CHRM5—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	1.01e-05	5.43e-05	CbGpPWpGaD
Nortriptyline—CYP2C9—Metabolism—DPYD—attention deficit hyperactivity disorder	1.01e-05	5.42e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	1e-05	5.39e-05	CbGpPWpGaD
Nortriptyline—ALB—Metabolism—SNAP25—attention deficit hyperactivity disorder	1e-05	5.38e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	1e-05	5.37e-05	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—ADRA2C—attention deficit hyperactivity disorder	9.81e-06	5.26e-05	CbGpPWpGaD
Nortriptyline—ALB—Metabolism—ADRA2A—attention deficit hyperactivity disorder	9.54e-06	5.12e-05	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	9.51e-06	5.11e-05	CbGpPWpGaD
Nortriptyline—CYP2D6—Metabolism—CACNA1C—attention deficit hyperactivity disorder	9.47e-06	5.08e-05	CbGpPWpGaD
Nortriptyline—CYP2C9—Metabolism—CACNA1C—attention deficit hyperactivity disorder	9.39e-06	5.04e-05	CbGpPWpGaD
Nortriptyline—CYP2C19—Metabolism—SNAP25—attention deficit hyperactivity disorder	9e-06	4.83e-05	CbGpPWpGaD
Nortriptyline—CYP2E1—Metabolism—COMT—attention deficit hyperactivity disorder	8.84e-06	4.75e-05	CbGpPWpGaD
Nortriptyline—CYP3A5—Metabolism—COMT—attention deficit hyperactivity disorder	8.82e-06	4.74e-05	CbGpPWpGaD
Nortriptyline—CYP2E1—Metabolism—MAOA—attention deficit hyperactivity disorder	8.78e-06	4.71e-05	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism—TPH2—attention deficit hyperactivity disorder	8.77e-06	4.71e-05	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism—CACNB2—attention deficit hyperactivity disorder	8.77e-06	4.71e-05	CbGpPWpGaD
Nortriptyline—CYP3A5—Metabolism—MAOA—attention deficit hyperactivity disorder	8.76e-06	4.7e-05	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism—DPYD—attention deficit hyperactivity disorder	8.63e-06	4.63e-05	CbGpPWpGaD
Nortriptyline—CYP2C19—Metabolism—ADRA2A—attention deficit hyperactivity disorder	8.57e-06	4.6e-05	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	8.29e-06	4.45e-05	CbGpPWpGaD
Nortriptyline—CYP2D6—Metabolism—SNAP25—attention deficit hyperactivity disorder	8.28e-06	4.44e-05	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	8.25e-06	4.43e-05	CbGpPWpGaD
Nortriptyline—CYP2C9—Metabolism—SNAP25—attention deficit hyperactivity disorder	8.21e-06	4.4e-05	CbGpPWpGaD
Nortriptyline—ALB—Hemostasis—EP300—attention deficit hyperactivity disorder	8.04e-06	4.31e-05	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism—CACNA1C—attention deficit hyperactivity disorder	8.02e-06	4.31e-05	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	7.89e-06	4.24e-05	CbGpPWpGaD
Nortriptyline—CYP2D6—Metabolism—ADRA2A—attention deficit hyperactivity disorder	7.88e-06	4.23e-05	CbGpPWpGaD
Nortriptyline—CYP2C9—Metabolism—ADRA2A—attention deficit hyperactivity disorder	7.81e-06	4.19e-05	CbGpPWpGaD
Nortriptyline—ALB—Metabolism—COMT—attention deficit hyperactivity disorder	7.6e-06	4.08e-05	CbGpPWpGaD
Nortriptyline—ALB—Metabolism—MAOA—attention deficit hyperactivity disorder	7.54e-06	4.05e-05	CbGpPWpGaD
Nortriptyline—ALB—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	7.32e-06	3.93e-05	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	7.28e-06	3.91e-05	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	7.15e-06	3.84e-05	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	7.12e-06	3.82e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	7.1e-06	3.81e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	7.03e-06	3.77e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	7.01e-06	3.76e-05	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism—SNAP25—attention deficit hyperactivity disorder	7.01e-06	3.76e-05	CbGpPWpGaD
Nortriptyline—CYP2C19—Metabolism—COMT—attention deficit hyperactivity disorder	6.82e-06	3.66e-05	CbGpPWpGaD
Nortriptyline—CYP2C19—Metabolism—MAOA—attention deficit hyperactivity disorder	6.77e-06	3.64e-05	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—TPH2—attention deficit hyperactivity disorder	6.77e-06	3.63e-05	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—CACNB2—attention deficit hyperactivity disorder	6.77e-06	3.63e-05	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism—ADRA2A—attention deficit hyperactivity disorder	6.67e-06	3.58e-05	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—DPYD—attention deficit hyperactivity disorder	6.66e-06	3.58e-05	CbGpPWpGaD
Nortriptyline—CYP2C19—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	6.57e-06	3.53e-05	CbGpPWpGaD
Nortriptyline—CYP2D6—Metabolism—COMT—attention deficit hyperactivity disorder	6.27e-06	3.37e-05	CbGpPWpGaD
Nortriptyline—CYP2D6—Metabolism—MAOA—attention deficit hyperactivity disorder	6.23e-06	3.34e-05	CbGpPWpGaD
Nortriptyline—CYP2C9—Metabolism—COMT—attention deficit hyperactivity disorder	6.22e-06	3.34e-05	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—CACNA1C—attention deficit hyperactivity disorder	6.19e-06	3.32e-05	CbGpPWpGaD
Nortriptyline—CYP2C9—Metabolism—MAOA—attention deficit hyperactivity disorder	6.17e-06	3.31e-05	CbGpPWpGaD
Nortriptyline—CYP2C9—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	5.99e-06	3.21e-05	CbGpPWpGaD
Nortriptyline—HTR6—Signaling Pathways—EP300—attention deficit hyperactivity disorder	5.93e-06	3.19e-05	CbGpPWpGaD
Nortriptyline—CHRM4—Signaling Pathways—EP300—attention deficit hyperactivity disorder	5.6e-06	3e-05	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—SNAP25—attention deficit hyperactivity disorder	5.41e-06	2.91e-05	CbGpPWpGaD
Nortriptyline—CHRM5—Signaling Pathways—EP300—attention deficit hyperactivity disorder	5.36e-06	2.88e-05	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism—COMT—attention deficit hyperactivity disorder	5.31e-06	2.85e-05	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism—MAOA—attention deficit hyperactivity disorder	5.28e-06	2.83e-05	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—ADRA2A—attention deficit hyperactivity disorder	5.15e-06	2.77e-05	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	5.12e-06	2.75e-05	CbGpPWpGaD
Nortriptyline—PTGS1—Metabolism—EP300—attention deficit hyperactivity disorder	5.07e-06	2.72e-05	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling Pathways—EP300—attention deficit hyperactivity disorder	5.04e-06	2.71e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Metabolism—EP300—attention deficit hyperactivity disorder	4.5e-06	2.42e-05	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—EP300—attention deficit hyperactivity disorder	4.39e-06	2.36e-05	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—EP300—attention deficit hyperactivity disorder	4.37e-06	2.35e-05	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—EP300—attention deficit hyperactivity disorder	4.18e-06	2.25e-05	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—COMT—attention deficit hyperactivity disorder	4.1e-06	2.2e-05	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—MAOA—attention deficit hyperactivity disorder	4.07e-06	2.19e-05	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—EP300—attention deficit hyperactivity disorder	3.86e-06	2.07e-05	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—EP300—attention deficit hyperactivity disorder	3.79e-06	2.04e-05	CbGpPWpGaD
Nortriptyline—CYP2E1—Metabolism—EP300—attention deficit hyperactivity disorder	3.79e-06	2.04e-05	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—EP300—attention deficit hyperactivity disorder	3.79e-06	2.03e-05	CbGpPWpGaD
Nortriptyline—CYP3A5—Metabolism—EP300—attention deficit hyperactivity disorder	3.78e-06	2.03e-05	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—EP300—attention deficit hyperactivity disorder	3.77e-06	2.03e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—EP300—attention deficit hyperactivity disorder	3.76e-06	2.02e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—EP300—attention deficit hyperactivity disorder	3.73e-06	2e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—EP300—attention deficit hyperactivity disorder	3.71e-06	1.99e-05	CbGpPWpGaD
Nortriptyline—ALB—Metabolism—EP300—attention deficit hyperactivity disorder	3.26e-06	1.75e-05	CbGpPWpGaD
Nortriptyline—CYP2C19—Metabolism—EP300—attention deficit hyperactivity disorder	2.92e-06	1.57e-05	CbGpPWpGaD
Nortriptyline—CYP2D6—Metabolism—EP300—attention deficit hyperactivity disorder	2.69e-06	1.44e-05	CbGpPWpGaD
Nortriptyline—CYP2C9—Metabolism—EP300—attention deficit hyperactivity disorder	2.67e-06	1.43e-05	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism—EP300—attention deficit hyperactivity disorder	2.28e-06	1.22e-05	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—EP300—attention deficit hyperactivity disorder	1.76e-06	9.44e-06	CbGpPWpGaD
